Nektar Therapeutics | NKTR - Nakit Ve Eşdeğer





Nakit Ve Eşdeğer Değişiklik Tarih
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
ALKERMES USD 351.55M 37.02M 2026-03
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 12.04B 2.91B 2026-03
Baxter International USD 2.02B 51M 2026-03
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Biogen USD 3.38B 374.2M 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Cara Therapeutics USD 21.42M 770K 2025-09
Cipla INR 7.96B 39.9M 2025-09
Dr.Reddys Laboratories INR 18.66B 8.75B 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 5.28B 1.99B 2026-03
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Exelixis USD 482.49M 106.19M 2025-12
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
Merck USD 5.33B 9.24B 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Pfizer USD 1.7B 561M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Takeda JPY 654.94B 26.55B 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xencor USD 54.07M 25.78M 2025-12